Sandeep Katiyar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sandeep Katiyar has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
A.G. Ghoshal
National Allergy Asthma Bronchitis Institute, Kolkata, West Bengal, India
1 shared publicationA.K. Janmeja
Department of Respiratory Medicine, Government Medical College, Chandigarh, India
1 shared publicationAbhishek Faye
Centre for Lung and Sleep Disorders, Nagpur, Maharashtra, India
1 shared publicationAditya Jindal
Jindal Clinic, Chandigarh, India
1 shared publication- Aloke Gopal Ghoshal
National Allergy Asthma Bronchitis Institute, Kolkata, India
1 shared publication Amit K. Murar
Respiratory Medicine, Cronus Multi-Specialty Hospital, New Delhi, India
1 shared publication
Latest Publications
- 11 July 2022
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 69, S1-S191
Indian Guidelines on Nebulization Therapy
- 11 July 2022
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 69, S1-S191
Indian Guidelines on Nebulization Therapy
- 1 October 2019
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 66 (4) , 507-515
Protocol for the management of newly diagnosed cases of tuberculosis
- 1 October 2019
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 66 (4) , 507-515
Protocol for the management of newly diagnosed cases of tuberculosis
- 15 March 2017
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (6) , 801-813
Interstitial Lung Disease in India. Results of a Prospective Registry
Rationale: Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little is known about the clinical profile of ILDs in India. Objectives: To characterize new-onset ILDs in India by creating a prospective ILD using multidisciplinary discussion (MDD) to validate diagnoses. Methods: Adult patients of Indian origin living in India with new-onset ILD (27 centers, 19 Indian cities, March 2012–June 2015) without malignancy or infection were included. All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography chest. ILD pattern was defined by high-resolution computed tomography images. Three groups independently made diagnoses after review of clinical data including that from prompted case report forms: local site investigators, ILD experts at the National Data Coordinating Center (NDCC; Jaipur, India) with MDD, and experienced ILD experts at the Center for ILD (CILD; Seattle, WA) with MDD. Cohen’s κ was used to assess reliability of interobserver agreement. Measurements and Main Results: A total of 1,084 patients were recruited. Final diagnosis: hypersensitivity pneumonitis in 47.3% (n = 513; exposure, 48.1% air coolers), CTD-ILD in 13.9%, and idiopathic pulmonary fibrosis in 13.7%. Cohen’s κ: 0.351 site investigator/CILD, 0.519 site investigator/NDCC, and 0.618 NDCC/CILD. Conclusions: Hypersensitivity pneumonitis was the most common new-onset ILD in India, followed by CTD-ILD and idiopathic pulmonary fibrosis; diagnoses varied between site investigators and CILD experts, emphasizing the value of MDD in ILD diagnosis. Prompted case report forms including environmental exposures in prospective registries will likely provide further insight into the etiology and management of ILD worldwide.
- 15 March 2017
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (6) , 801-813
Interstitial Lung Disease in India. Results of a Prospective Registry
Rationale: Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little is known about the clinical profile of ILDs in India. Objectives: To characterize new-onset ILDs in India by creating a prospective ILD using multidisciplinary discussion (MDD) to validate diagnoses. Methods: Adult patients of Indian origin living in India with new-onset ILD (27 centers, 19 Indian cities, March 2012–June 2015) without malignancy or infection were included. All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography chest. ILD pattern was defined by high-resolution computed tomography images. Three groups independently made diagnoses after review of clinical data including that from prompted case report forms: local site investigators, ILD experts at the National Data Coordinating Center (NDCC; Jaipur, India) with MDD, and experienced ILD experts at the Center for ILD (CILD; Seattle, WA) with MDD. Cohen’s κ was used to assess reliability of interobserver agreement. Measurements and Main Results: A total of 1,084 patients were recruited. Final diagnosis: hypersensitivity pneumonitis in 47.3% (n = 513; exposure, 48.1% air coolers), CTD-ILD in 13.9%, and idiopathic pulmonary fibrosis in 13.7%. Cohen’s κ: 0.351 site investigator/CILD, 0.519 site investigator/NDCC, and 0.618 NDCC/CILD. Conclusions: Hypersensitivity pneumonitis was the most common new-onset ILD in India, followed by CTD-ILD and idiopathic pulmonary fibrosis; diagnoses varied between site investigators and CILD experts, emphasizing the value of MDD in ILD diagnosis. Prompted case report forms including environmental exposures in prospective registries will likely provide further insight into the etiology and management of ILD worldwide.